Alexandria Pharmaceuticals General Assembly Approves EGP 4.5 Dividend/share

The General Assembly of Alexandria Pharmaceutical and Chemical Industries (AXPH.CA) has approved dividend distribution for the fiscal year of 2011/2012 hit EGP 20.250 million; EGP 4.5 per share.

Central Auditing Organization has ratified the company’s financial statements for the fiscal year ended on 30/06/2012 as well as the business results.

Worth mentioning, Alexandria Pharmaceuticals’ financial results for FY2011/12 revealed a net profit of EGP 44.26 million, 6.6% down from a net profit of EGP 47.365 million a year earlier.